Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Rebekah M Ahmed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: C9orf72 Protein, Body Composition, Thalamus, Frontotemporal Dementia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
BACKGROUND Patients with sporadic frontotemporal dementia (FTD) display changes in metabolism and body composition. No studies have examined body composition changes in pre‐symptomatic C9orf72 mutation carriers METHODS Asymptomatic C9orf72 expansion carriers between 2017 and 2022 ( n = 28 non‐carriers, 16 expansion‐positive), underwent dual‐energy X‐ray absorptiometry (measurement of changes in body composition) and brain magnetic resonance imaging (MRI). RESULTS Changes in body composition were identified in the C9orf72 expansion carrier group compared to non‐carrier group (average 11–12 years prior to onset): lower android‐to‐gynoid ratio ( p = 0.009), and visceral adipose tissue area ( p = 0.010). Lower android‐to‐gynoid ratio and lean mass were associated with lower volumes across the cortex, subcortex, and thalamus. CONCLUSIONS The current study highlights that genetically at‐risk C9orf72 patients exhibit altered body composition. These findings align with the growing recognition that changes in genetic frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS) extend beyond cognitive/motor symptoms and include early alterations in broader physiological function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Mind Centre, The University of Sydney, Sydney, Australia.
- Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia.
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
- School of Medical Sciences, The University of Sydney, Sydney, Australia.
- School of Psychology, The University of Sydney, Sydney, Australia.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Ahmed, R. M., Tse, N. Y., Bocchetta, M., Dobson-Stone, C., Kwok, J. B., Hodges, J. R., Irish, M., Rohrer, J. R., Piguet, O., & Halliday, G. (2026). Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71669
Vancouver
Ahmed RM, Tse NY, Bocchetta M, Dobson-Stone C, Kwok JB, Hodges JR, et al. Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71669
BibTeX
@article{Ahmed2026,
author = {Ahmed, Rebekah M and Tse, Nga Yan and Bocchetta, Martina and Dobson-Stone, Carol and Kwok, John B and Hodges, John R and Irish, Muireann and Rohrer, Jonathan R and Piguet, Olivier and Halliday, Glenda},
title = {Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71669}
}
EUVIMED